Cargando…
Tacrolimus-Induced Hyponatremia in Lung Transplant Recipients: A Case Series
BACKGROUND: Lung transplant recipients are treated with a 3-drug immunosuppressive regimen that consists of a calcineurin inhibitor, an antiproliferative agent, and a corticosteroid. Calcineurin inhibitors are the backbone of this regimen, and tacrolimus is used more often than cyclosporine, because...
Autores principales: | Banks, Paul N., Omar, Ashraf, Walia, Rajat, Bhalla, Sarabjit, Chong, Yun, Tokman, Sofya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908455/ https://www.ncbi.nlm.nih.gov/pubmed/29707630 http://dx.doi.org/10.1097/TXD.0000000000000774 |
Ejemplares similares
-
Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
por: Sindu, Devika, et al.
Publicado: (2023) -
Lung Transplant Candidates With Pretransplant Gastroesophageal Reflux and Antibodies to Lung Self-antigens Have Shorter CLAD-free Survival After Transplant
por: Razia, Deepika, et al.
Publicado: (2022) -
Lung cancer in recipients after lung transplant: single-centre experience and literature review
por: Lashari, Bilal Haider, et al.
Publicado: (2022) -
Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients
por: Katahira, Masato, et al.
Publicado: (2020) -
Detection of Bacterial Colonization in Lung Transplant Recipients Using an Electronic Nose
por: Wijbenga, Nynke, et al.
Publicado: (2023)